口服班达穆斯丁与静脉注射在治疗血液性恶性瘤中的有效性相比较
Megan J Cracchiolo1, Lisa Davis2, Andrew P Matiatos1
1Department of Pediatrics, University of Arizona, 1501 N. Campbell Ave., PO Box 245073, Tucson, AZ, 85724-5073, USA.
一种新的口服班达穆斯丁配方显示了与静脉注射班达穆斯丁相似的抗瘤疗效,在小鼠中口服生物可用性为51.4%. 这种口服药物显示出在癌症治疗中临床使用的潜力.
科学领域:
- 药理学和瘤学 药理学和瘤学
- 药物输送系统 药物输送系统
- 纳米技术纳米技术
背景情况:
- 班达穆斯丁是一种已知的化疗剂,用于治疗各种血液性恶性瘤.
- 目前,本达穆斯丁主要是静脉注射 (IV),这限制了患者的方便性,并可能增加医疗保健成本.
- 开发替代的管理路径,如口服 (PO),是可取的,以改善患者的遵守和可访问性.
研究的目的:
- 评估和比较一种新型纳米粒子配方的口服bendamustine (PO bendamustine) 与传统的静脉注射bendamustine (IV bendamustine) 的抗瘤疗效和药理动力学.
- 评估两种给药途径对相关癌细胞系的体外和体外细胞毒性.
- 为了确定新 PO bendamustine 配方的药理动力学特征,包括口服生物可用性.
主要方法:
- 使用液体染色体质谱法对接受IV或PO达姆斯丁治疗的小鼠血样本的药理动力学分析.
- 通过MTS试验对Bendamustine对人类非霍奇金伯基特淋巴瘤,多发性髓瘤和B细胞急性淋巴细胞白血病细胞系的体内细胞毒性评估.
- 在异种移植模型中使用 luciferase 标记的细胞系进行体内抗瘤疗效评估,这些细胞系接受了 IV 和 PO bendamustine 治疗.
主要成果:
- 实验室研究证实,在高度下,班达慕斯会诱导细胞死亡.
- 在三个异种移植模型中,在生理学上相关的度下,IV和新 PO bendamustine 之间没有观察到抗瘤活性的显著差异.
- 活体内药理动力学研究显示,在小鼠中,bendamustine的口服生物利用率为51.4%.
结论:
- 这种新型的口服班达穆斯丁配方表现出良好的口服生物可用性和全身暴露,导致与IV班达穆斯丁可比的体内抗瘤疗效.
- 开发的口服班达穆斯丁药物是一种有前途的替代注射途径,具有显著的临床潜力.
- 需要进一步的临床研究来验证这种口服班达穆斯丁配方的疗效和安全性.
更多相关视频
11:25Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
Published on: April 1, 2015
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
相关概念视频
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
